Founded in 2004 and based in Alameda, California, Penumbra Inc. (PEN) is an innovative global healthcare company that designs, develops, manufactures, and markets innovative and life-saving medical devices. The company, under the guidance of CEO Adam Elsesser, is dedicated to addressing some of the world's most challenging medical conditions and improving patient outcomes.
Primarily, Penumbra focuses on products that address neurological conditions and peripheral vascular disease. One of their significant contributions to healthcare technology includes the Penumbra System, a device used for mechanical thrombectomy, especially in acute ischemic stroke patients. This device helps remove blood clots blocking the flow of blood in the brain, consequently reducing disability or death caused by stroke.
In addition, Penumbra also manufactures and markets embolization devices used to treat hemorrhagic stroke and various peripheral vascular conditions as well as aspiration-based thrombectomy systems for peripheral applications.
Year after year, Penumbra’s commitment to continuous innovation has led the company to introduce novel products that transform the medical industry. For instance, Penumbra launched a new generation stroke devices, such as ACE68 Reperfusion Catheter and Penumbra ENGINE aspiration source. In 2015, they introduced the 3D Revascularization Device, which signaled a new era of treatment for acute ischemic stroke.
The company operates globally, with direct sales in the United States, Europe, Canada and Australia, and distributor relationships in other markets worldwide. Penumbra Inc. employs over 2000 people and is publicly traded on the New York Stock Exchange under the ticker symbol “PEN”.
In terms of financial performance, Penumbra has shown steady growth over the years. Revenue reports show consistent increases and the company seems to be on a promising path towards future success.
Penumbra Inc.'s mission is to continuously drive innovation and offer advanced treatment options to healthcare providers and patients. The company is guided by the principle of benefiting patients, striving to develop and provide safer, more effective therapies. In conclusion, Penumbra Inc. is a pioneering firm in healthcare, committed to transforming the field with groundbreaking medical technology, benefiting the lives of millions worldwide.